【罗氏(RHHBY.US)伐米奇拜单抗注射液的上市申请获CDE受理 用于治疗葡萄膜炎性黄斑水肿】智通财经APP获悉,9月3日,CDE官网显示,罗氏(RHHBY.US)伐米奇拜单抗注射液的上市申请获得受理,用于治疗葡萄膜炎性黄斑水肿(UME)。此前,该申请已被CDE纳入优先审评审批程序。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.